ARCHIVES

FDA Approves Ribavirin Phase 102 Trials

This article is from The Cancer Letter archive.

Vol. 13 No. 42 | October 30, 1987

Download PDF Visit The Full Archive

Related Articles

Trastuzumab Increases Risks Of Congestive Heart Failure

August 31, 2012

Hydridoma Cell Lines Available

March 5, 1982

M.D. Anderson Opens Centers For Social Workers, Outpatients

November 21, 1986

In Brief: NCAB Will Consider Holding “Circuit Rider” Meetings; Kaplan Asked to Speak On Hybridomas

May 1, 1981

AACR, NCCR Advocate Five-Year Plan to Reach $10 billion Annual Cancer Budget

April 30, 1999

Zometa Prevents Bone Loss In Premenopausal Women

August 29, 2008